Acquisitions, Divestitures and Strategic Investments - Narrative (Details) - USD ($) $ in Millions					3 Months Ended
	Apr. 01, 2025	Mar. 03, 2025	Jan. 24, 2025	Nov. 25, 2024	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Business Combination [Line Items]
Payment for acquisition, net of cash acquired					$ 239	$ 47
Business Combination, Contingent Consideration, Liability					214		$ 171
Uncapped Contingent Considertation					151
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity					374
Bolt Medical, Inc.
Business Combination [Line Items]
Equity Method Investment, Ownership Percentage	26.00%
SoniVie Ltd
Business Combination [Line Items]
Equity Method Investment, Ownership Percentage		10.00%
Cortex, Inc.
Business Combination [Line Items]
Payment for acquisition, net of cash acquired			$ 239		239
Business Combination, Contingent Consideration, Liability			$ 50		38
Business Combination, Voting Equity Interest Acquired, Percentage			100.00%
Intera Oncology
Business Combination [Line Items]
Payment for acquisition, net of cash acquired				$ 175
Business Combination, Voting Equity Interest Acquired, Percentage				100.00%
Bolt Medical, Inc.
Business Combination [Line Items]
Payment for acquisition, net of cash acquired	$ 516
Business Combination, Contingent Consideration, Liability	$ 148
All Business Acquisitions
Business Combination [Line Items]
Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount					$ 270
SoniVie Ltd
Business Combination [Line Items]
Payment for acquisition, net of cash acquired		$ 360
Business Combination, Contingent Consideration, Liability		$ 180